1 |
Grier CK, Mayer MN. Radiation therapy of canine nontonsillar squamous cell carcinoma. Can Vet J 2007; 48: 1189-1191.
|
2 |
Henkels KM, Turchi JJ. Carboplatin-induced apoptosis proceeds by caspase-3-dependent and independent pathways in cisplatin-rresistant and sensitive human ovarian cancer. Cancer Res 1999; 59: 3077-3083.
|
3 |
de Vos JP, Burm AG, Focker AP, Boschloo H, Karsijns M, van der Waal I. Piroxicam and carboplatin as a combination treatment of canine oral non-tonsillar squamous cell carcinoma: a pilot study and a literature review of a canine model of human head and neck squamous cell carcinoma. Vet Comp Oncol 2005; 3: 16-24.
DOI
ScienceOn
|
4 |
Brooks MB, Matus RE, Leifer CE, Alfieri AA, Patnaik AK. Chemotherapy versus chemotherapy plus radiotherapy in the treatment of tonsillar squamous cell carcinoma in the dog. J Vet Intern Med 1988; 2: 206-211.
DOI
|
5 |
Mohammed SI, Bennett PF, Craig BA, Glickman NW, Mutsaers AJ, Snyder PW, Widmer WR, De Nicola DB, Knapp DW. Effects of the cyclooxgenase inhibitor, piroxicam, on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer. Cancer Res 2002; 62: 356-358.
|
6 |
Cohen D, Brodey RS, Chen SM. Epidemiologic Aspects of Oral and Pharyngeal Neoplasms of the Dog. Am J Vet Res 1964; 25: 1776-1779.
|
7 |
Boria PA, Murry DJ, Bennett PF, Glickman NW, Snyder PW, Merkel BL, Schlittler DL, Mutsaers AJ, Thomas RM, Knapp DW. Evaluation of cisplatin combined with piroxicam for the treatment of oral malignant melanoma and oral squamous cell carcinoma in dogs. J Am Vet Med Assoc 2004; 224: 388-394.
DOI
ScienceOn
|
8 |
Schmidt BR, Glickman NW, DeNicola DB, de Gortari AE, Knapp DW. Evaluation of piroxicam for the treatment of oral squamous cell carcinoma in dogs. J Am Vet Med Assoc 2001; 218: 1783-1786.
DOI
ScienceOn
|
9 |
Wallace J, Matthiesen DT, Patnaik AK. Hemimaxillectomy for the treatment of oral tumors in 69 dogs. Vet Surg 1992; 21: 337-341.
DOI
ScienceOn
|
10 |
Mohammed SI, Craig BA, Mutsaers AJ, Glickman NW, Snyder PW, de Gortari AE, Schlittler DL, Coffman KT, Bonney PL, Knapp DW. Effects of cyclooxygenase inhibitor, piroxicam, in combination with chemotherapy on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer. Mole Cancer Ther 2003; 2: 183-188.
DOI
|
11 |
Liptak JM, Withrow SJ. Cancers of the Gastrointestinal tract. In: Small Animal Clinical Oncology, 4th ed. Philadelphia: Saunders Elsevier. 2007: 455-475.
|
12 |
Mohammed SI, Coffman K, Glickman NW, Hayek MG, Waters DJ, Schlittler D, DeNicola DB, Knapp DW. Prostaglandin E2 concentrations in naturally occurring canine cancer. Prostaglandins Leukot Essent Fatty Acids 2001; 64: 1-4.
DOI
ScienceOn
|
13 |
Makitie AA, Chau M, Lim S, Viani MA, Gilbert R, Lim MS, Jordan RC. Selective inhibition of cyclooxygenase 2 induces p27kip1 and skp2 in oral squamous cell carcinoma. J Otolaryngology 2003; 32: 226-229.
DOI
ScienceOn
|
14 |
MacMillan R, Withrow SJ, Gillette EL. Surgery and regional irradiation for treatment of canine tonsillar squamous cell carcinoma: retrospective review of eight cases. J Am Anim Hosp Associ 1982; 18: 311-314.
|
15 |
Kosovsky JK, Matthiesen DT, Marretta SM, Patnaik AK. Results of partial mandibulectomy for the treatment of oral tumors in 142 dogs. Vet Surg 1991; 20: 397-401.
DOI
ScienceOn
|